Protective effect study of major constituent in total panax notoginsenoside on rat brain microvessel endothelial cell (RBMEC) damage induced by H 2O2

Chinese Pharmacological Bulletin

Volumn 23, Issue 8, 2007, Pages 1030-1034

  Li, Xiao Yu ^a   Sun, Jian Guo ^a   Zheng, Yuan Ting ^a   Wu, Xiao Lan ^a   Li, Yan Nan ^a   Xin, Chun Hua ^a   Gu, Shu Jing ^a   Wang, Guang Ji ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Major constituent; Primary culture; Rat brain microvessel endothelial cell (RBMEC); Total panax notoginsenoside (TPNS)

Indexed keywords

HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; PANAX NOTOGINSENG EXTRACT;

ANIMAL CELL; ARTICLE; BRAIN CELL; CELL CULTURE; CELL DAMAGE; CELL ISOLATION; CONTROLLED STUDY; ENDOTHELIUM CELL; MICROVASCULATURE; NONHUMAN; RAT;

EID: 35148876578     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Li H, Deng C Q, Chen B Y, et al. Effects of panax notoginseng saponins on expression of Caspase after focal cerebral ischemia-reperfusion in rats[J]. Chin Pharmacol Bull, 2006,22(2):189-93.
2. He J. Pharmacology and advance research of total panax notogin-senoside[J]. Tianjin Pharm, 2004,16(5):58-60.
3. Bao J C, Liu G, Cong D L, et al. Advance research of chemical component in Panax Notoginsenoside[J]. Chin Trad Patent Med, 2006,28(2):246- 53.
4. Ma J G. Clinical studies of XUESAITONG injection on the treatment of ischemic cerebral infarction[J]. Sandong J Trad Chin Med, 2005,24(1):24 -5.
5. Zhang Y X, Lu R B. Clinical observation of XUESAITONG injection on the treatment of Hemorrhagic stroke[J]. Chin J Emerg Trad Chin Med, 2005,14(3):236.
6. 2[J]. Chin J Pathophysiol, 2006,22(5):929-32.
7. Fujimura M, Gache Y, Moritar Fujimura Y, et al. Early appearance of activated matrix metalloproteinase-9 and blood brain barrier distruption in mice after focal cerebral ischemia and reperfusion[J]. Brain Res, 1999,842(1):92-100.
8. Zhao F, Hu S R, Yang S P. Clinical and empirical study of Xuesaitong injection on the treatment of cerebrovascular disease[J]. Guangdong Med, 1985,6(8):30-2.
9. Mo N, Zhou Y. The inhibitory effects of PNS on cardiac hypertrophy and its nervous mechanism[J]. Chin Pharmacol Bull, 2004, 20(10):1131- 4.
10. Si Y C, Li J W, Zhu P C. The expression of excitatory amino acids receptor NR2A and NR2B subunits of NMDA receptor in rats forebrain after ICH and the effects of panax notoginseng saponins[J]. Chin Pharmacol Bull, 2005,21(10):1280.
11. Ma L Y, Xiao P G, Liang F Q, et al. Protective effects of panax notoginseng saponins on primary cortical cultures of rats[J]. J Chin Pharm, 1998,33(3):143-5.
12. Y an Y F, Zhang Z, Sun S L, et al. Protective effects of total saponin of panax notoginseng ang notoginsenosides on the hypoxia induced damage of cultured vascular endothelial cells in vitro[J]. Chin J Exp Trad Med Formul, 2002,8(1):34-7.
13. Mosmann T R, Fong A T. Specific assays for cytokine production by T cells[J]. J Immunol Meth, 1989,116(2):151-8.
14. Kristian T, SiesjoB. Calcium-related damage in ischemia[J]. Life Sci Includ Pharmacol Lett, 1996,59(5-6):357-67.